Submitted by Anonymous (not verified) on 9 December 2025 - 14:40
Human medicines European public assessment report (EPAR): Inbrija, levodopa, Date of authorisation: 19/09/2019, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Inbrija, levodopa, Date of authorisation: 19/09/2019, Revision: 7, Status: Authorised